Advertisement
Advertisement
U.S. markets close in 5 hours 30 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Meridian Bioscience, Inc. (VIVO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
30.53+0.07 (+0.23%)
As of 10:28AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Performance Outlook
Previous Close30.46
Open31.23
Bid30.65 x 1400
Ask30.67 x 900
Day's Range30.26 - 30.72
52 Week Range17.04 - 31.93
Volume105,022
Avg. Volume384,975
Market Cap1.33B
Beta (5Y Monthly)0.34
PE Ratio (TTM)21.64
EPS (TTM)1.41
Earnings DateAug 04, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateFeb 01, 2019
1y Target Est30.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VIVO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Meridian Bioscience Inc.
    VIVO: Raising target price to $32.00MERIDIAN BIOSCIENCE INC has an Investment Rating of BUY; a target price of $32.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
Advertisement
Advertisement